Compare Newegg Commerce Inc (NEGG) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newegg Commerce Inc vs Sanofi SA — how do they compare? Newegg Commerce Inc trades at $14.93 (market cap $315.03M), while Sanofi SA trades at $43.12 (market cap $103.41B). The key difference: Sanofi SA is far larger — about 328.3× Newegg Commerce Inc's market cap, and Sanofi SA pays a 5.65% dividend while Newegg Commerce Inc pays none. Which is the better fit depends on your goals.
| NEGG | SNY | |
|---|---|---|
Market Cap | $315.03M | $103.41B |
Sector | Consumer Cyclical | Health |
52-Week High | $92.74 | $52.34 |
52-Week Low | $12.87 | $41.33 |
Enterprise Value | $285.26M | $123.44B |
Dividend Yield | — | 5.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $15.17, down 0.98% on the day, with a bearish technical signal but improving fundamentals. Recent quarterly earnings consistently beat expectations, including Q2 2026 EPS of $0.11 versus -$0.40 estimated. Revenue stabilized around $1.4 billion in 2025-2026, with net income turning positive in 2026. The company announced partnerships with Hewlett Packard Enterprise and launched AI shopping features, indicating strategic growth initiatives.
The outlook is cautiously optimistic due to earnings momentum and low P/S ratio of 0.23, but risks include negative operating cash flow in 2025 and high current liabilities. Analyst consensus is 100% buy, though based on limited coverage. Investors should weigh profitability improvements against liquidity concerns and competitive e-commerce pressures.
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
